drugset / Trial / NCT02161055

Intensive Versus Nonintensive Insulin Therapy for Hyperglycemia After Traumatic Brain Injury

NCT02161055

RandomizedParallel-groupOpen-labelTreatment

Summary

An increase in blood glucose is a common clinical symptom in patients following traumatic brain injury. Studies confirm that death after traumatic brain injury was not only associated with nerve injury, but also correlated with abnormal physiological and metabolic reactions. Hyperglycemia is a manifestation of physiological and metabolic disorders after traumatic brain injury. Traumatic brain injury induced hyperglycemia, and then aggravated secondary injury to the brain. Therefore, it is of important clinical significance to study the treatment of hyperglycemia after traumatic brain injury.

Timeline

Start
2014-06
Primary completion
2016-06
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin Protein / enzyme biologic Intravenous